Skip to content

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHYAGOKSHURADI KWATHA AND SHATAVARYADI KWATHA IN PITTAJA MUTRAKRICCHRA

A RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHYAGOKSHURADI KWATHA AND TO COMPARE IT WITH SHATAVARYADI KWATHA IN PAITTIKA MUTRAKRICCHRA

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037733
Enrollment
60
Registered
2021-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

MURALIDHAR A MIRAJKAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient within the age group of 16-60 years, who will give their written consent, who will agree to follow the protocol of study. Patients with classical symptoms of pittaja mutrakricchra like peeta mutrata, sarakta mutrata, daaha mutrata, rujayukta mutrata and muhur mutrata.

Exclusion criteria

Exclusion criteria: Paittika mutrakricchra caused due to marmabhighata, due to congenital deformity, due to STD. Vulnerable groups like pregnant women, lactating mother. Patients with other systemic disorders like diabetes mellitus, thyroid disorders, cardiac illness and other disorders which interfere with the treatment. Secondary to disorders like Asthma, BPH, acute renal failure, vesico-ureteric reflux, tumor, renal tuberculosis. Patients who are not willing to consent.

Design outcomes

Primary

MeasureTime frame
THE EFFECT OF THE TREATMENT WILL BE ASSESSED BASED ON DETAILED CASE PROFORMA ADOPTING STANDARD SCORING METHODS OF SUBJECTIVE PARAMETERS SUCH AS PAINFUL MICTURITION BURNING MICTURITION DIFFICULTY IN MICTURITION FREQUENCY OF MICTURITION NOCTURIA AND OBJECTIVE PARAMETERS SUCH AS YELLOW COLORATION OF URINE HEMATURIA PUS CELLS/HPF EPITHELIAL CELLS/HPF RBCS/HPF. PRE AND POST INTERVENTIONAL ASSESSMENT WILL BE DONE.Timepoint: AT BASELINE 4TH DAY 8TH DAY AND 15TH DAY

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR MEGHA MIRAJKAR

Yenepoya Ayurveda Medical College

drzenicadsouza@gmail.com7829727441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026